| Description | Timtraxanib (AVI-3207) is a potent and specific inhibitor of VEGF-2, offering great potential for investigating senile macular degeneration. |
| In vitro | Timtraxanib (AVI-3207) is a selective VEGF-2 inhibitor[1]. |
| Synonyms | AVI-3207 |
| molecular weight | 621.692 |
| Molecular formula | C28H43N7O9 |
| CAS | 2412172-33-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Avixgen secured 4 Clinical Pipelines … “Expansion of AIDS Clinical Trial to USA” |